Outline of JACLS ALL-02 treatment. Details of treatment elements are
PDF) Risk-adjusted therapy of acute lymphoblastic leukemia can
Six-Year Experience With a Comprehensive Approach to the Treatment
Integration of RNA Sequencing, Whole Exome Sequencing, and Flow
Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
Transplantation in Children and Adolescents with Acute
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version - Siteman Cancer Center
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Acute Lymphoblastic Leukemia
Long-term results of five consecutive trials in childhood acute
High-Risk Pediatric Acute Lymphoblastic Leukemia: To Transplant or Not to Transplant? - Biology of Blood and Marrow Transplantation
